微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 11.73% | -27.55% | 47.92% | 5/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 7.93% | -18.83% | 125.93% | 4/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 3.51% | -22.52% | -81.78% | 5/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 19.26% | -1.33% | 18.96% | 3/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 16.19% | -8.63% | 65.71% | 5/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 9.77% | 3.39% | 115.67% | 6/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 4.53% | 8.89% | -76.79% | 8/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 19.52% | 71.98% | 10.16% | 10/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 17.72% | 73.22% | 87.51% | 12/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 9.45% | 54.41% | 127.16% | 15/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 4.16% | -6.09% | -63.35% | 13/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 11.35% | 9.13% | 10.95% | 26/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 10.23% | -13.96% | 67.16% | 21/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 6.12% | -1.13% | 38.15% | 21/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 4.43% | 107.01% | -57.4% | 9/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | 10.4% | -4.67% | -12.53% | 28/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | 11.89% | 20.22% | 92.08% | 13/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | 6.19% | 13.58% | 189.25% | 13/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | 2.14% | -21.61% | -80.38% | 8/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | 10.91% | -34% | 10.31% | 26/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | 9.89% | -56.28% | 81.47% | 14/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | 5.45% | -49.02% | 99.63% | 13/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | 2.73% | -33.25% | -83.48% | 9/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | 16.53% | -2.36% | -26.92% | 13/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | 22.62% | 58.63% | 111.6% | 3/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | 10.69% | 2% | 161.37% | 3/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 4.09% | -19.8% | -75.84% | 3/51 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | 16.93% | -35.55% | 18.72% | 9/51 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 14.26% | 2% | 179.61% | 5/51 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-03-31 | 5.1% | 2% | -80.59% | 3/51 | -5.59% | 爱尔眼科 | 20.87% | 行业排名> |
| 2016-12-31 | 26.27% | 193.85% | 193.85% | 5/51 | 23.06% | 南华生物 | 1666.98% | 行业排名> |
| 2015-12-31 | 8.94% | -12.27% | -12.27% | 18/51 | 22.23% | 爱尔眼科 | 5.19% | 行业排名> |